Carl Zeiss Meditec AG (ETR:AFX - Get Free Report) was up 2.3% during mid-day trading on Friday . The stock traded as high as €47.00 ($48.45) and last traded at €46.56 ($48.00). Approximately 224,325 shares traded hands during mid-day trading, an increase of 138% from the average daily volume of 94,405 shares. The stock had previously closed at €45.52 ($46.93).
Carl Zeiss Meditec Price Performance
The stock has a 50 day moving average of €54.62 and a 200-day moving average of €60.46. The company has a debt-to-equity ratio of 6.74, a quick ratio of 2.47 and a current ratio of 3.51. The company has a market cap of $4.12 billion, a PE ratio of 20.18, a price-to-earnings-growth ratio of 2.83 and a beta of 0.98.
Carl Zeiss Meditec Company Profile
(
Get Free Report)
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders.
Featured Stories
Before you consider Carl Zeiss Meditec, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Carl Zeiss Meditec wasn't on the list.
While Carl Zeiss Meditec currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
